Euclidean Technologies Management, LLC Meridian Bioscience Inc Transaction History

Euclidean Technologies Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 28, 2022	SELL	$30.9 - $33.55 $309,000 - $335,500	-10,000 Reduced 13.7%	62,995 $1.99 Million
Q2 2022 Jul 25, 2022	SELL	$23.75 - $31.69 $190,000 - $253,520	-8,000 Reduced 9.88%	72,995 $2.22 Million
Q1 2022 Apr 28, 2022	SELL	$19.97 - $26.94 $889,843 - $1.2 Million	-44,559 Reduced 35.49%	80,995 $2.1 Million
Q4 2021 Feb 09, 2022	SELL	$17.46 - $21.61 $44,243 - $54,759	-2,534 Reduced 1.98%	125,554 $2.56 Million
Q2 2021 Aug 05, 2021	BUY	$18.01 - $28.32 $225,431 - $354,481	12,517 Added 10.83%	128,088 $2.84 Million
Q4 2020 Feb 10, 2021	BUY	$15.73 - $21.66 $629,200 - $866,400	40,000 Added 52.93%	115,571 $2.16 Million
Q3 2020 Nov 16, 2020	BUY	$13.54 - $26.41 $1.02 Million - $2 Million	75,571 New	75,571 $1.28 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Euclidean Technologies Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Euclidean Technologies Management, LLC with notifications on news.